Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · LANSING, MI · NPI 1073033197
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 681 | 182 |
| Lisinopril | Lisinopril | 525 | 151 |
| Levothyroxine Sodium | Levothyroxine Sodium | 400 | 113 |
| Omeprazole | Omeprazole | 369 | 110 |
| Losartan Potassium | Losartan Potassium | 310 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 302 | 91 |
| Metformin Hcl | Metformin Hcl | 291 | 89 |
| Tamsulosin Hcl | Tamsulosin Hcl | 247 | 71 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 228 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 226 | 68 |
| Gabapentin | Gabapentin | 219 | 52 |
| Fluticasone Propionate | Fluticasone Propionate | 203 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 197 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 196 | 56 |
| Simvastatin | Simvastatin | 189 | 54 |
| Montelukast Sodium | Montelukast Sodium | 184 | 54 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 183 | 64 |
| Mounjaro | Tirzepatide | 133 | 32 |
| Tramadol Hcl | Tramadol Hcl | 127 | 25 |
| Glipizide Er | Glipizide | 115 | 33 |
| Allopurinol | Allopurinol | 113 | 37 |
| Eliquis | Apixaban | 109 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 104 | 26 |
| Furosemide | Furosemide | 104 | 33 |
| Alprazolam | Alprazolam | 95 | 23 |
| Jardiance | Empagliflozin | 93 | 26 |
| Sertraline Hcl | Sertraline Hcl | 89 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 87 | 38 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 86 | 23 |
| Carvedilol | Carvedilol | 85 | 27 |
| Potassium Chloride | Potassium Chloride | 84 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 32 |
| Trazodone Hcl | Trazodone Hcl | 83 | 30 |
| Rybelsus | Semaglutide | 79 | 21 |
| Ezetimibe | Ezetimibe | 76 | 25 |
| Meloxicam | Meloxicam | 74 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 72 | 20 |
| Ibuprofen | Ibuprofen | 67 | 19 |
| Metformin Hcl Er | Metformin Hcl | 66 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 66 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 64 | 18 |
| Finasteride | Finasteride | 64 | 16 |
| Bupropion Xl | Bupropion Hcl | 63 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 61 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 61 | 32 |
| Trulicity | Dulaglutide | 61 | 11 |
| Lovastatin | Lovastatin | 60 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 22 |
| Pregabalin | Pregabalin | 53 | 12 |
| Clonazepam | Clonazepam | 51 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 14 |
| Atenolol | Atenolol | 48 | 14 |
| Bumetanide | Bumetanide | 48 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 15 |
| Xarelto | Rivaroxaban | 48 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 47 | 43 |
| Alendronate Sodium | Alendronate Sodium | 46 | 15 |
| Azithromycin | Azithromycin | 45 | 43 |
| Buspirone Hcl | Buspirone Hcl | 44 | 13 |
| Loperamide | Loperamide Hcl | 42 | 17 |
| Prednisone | Prednisone | 41 | 29 |
| Enalapril Maleate | Enalapril Maleate | 40 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 38 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 38 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 29 |
| Diazepam | Diazepam | 35 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 34 | 23 |
| Famotidine | Famotidine | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | 20 |
| Febuxostat | Febuxostat | 30 | suppressed |
| Ozempic | Semaglutide | 30 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Lidocaine | Lidocaine | 26 | 14 |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Nystatin | Nystatin | 25 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 11 |
| Ondansetron Odt | Ondansetron | 24 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Olanzapine | Olanzapine | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | suppressed |
| Eszopiclone | Eszopiclone | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Spironolactone | Spironolactone | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Ciclopirox | Ciclopirox | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 12 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 11 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 13 |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | 11 |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 12 |
| Triazolam | Triazolam | 13 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error